Skip to main content
Carelabs Co.,Ltd logo

Carelabs Co.,Ltd — Investor Relations & Filings

Ticker · 263700 ISIN · KR7263700007 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 455 across all filing types
Latest filing 2020-11-19 AGM Information
Country KR South Korea
Listing KO 263700

About Carelabs Co.,Ltd

https://www.carelabs.co.kr/

Carelabs Co., Ltd. is a platform company that provides comprehensive IT services for the healthcare and beauty care sectors. The company develops and operates solutions aimed at creating a more convenient and accessible healthcare ecosystem by resolving imbalances in medical information. Its core services include specialized customer relationship management (CRM) software for hospitals, such as 'SmartCRM' and 'UnoCRM', which support patient management and marketing activities. Additionally, Carelabs offers performance-based digital marketing services tailored to clients in the medical field. Through its technology-driven platforms, the company facilitates online-to-offline (O2O) connections within the health and beauty markets.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice regarding the convocation of an Extraordinary General Meeting (EGM) for Carelabs. It details the agenda, including the appointment of directors and the granting of stock options. This type of document, which provides information to shareholders to request their participation and votes for a meeting, is classified as a Proxy Solicitation & Information Statement.
2020-11-19 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Carelabs' covering the period from January 1, 2020, to September 30, 2020. It contains detailed corporate information, business overview, history, and capital structure, which are characteristic of a comprehensive interim financial report filed with the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). 9M 2020
2020-11-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership, changes in holdings, and major contracts (such as stock loans and collateral) of a major shareholder (DAYLI BlockChain Co., Ltd.) and its special related parties in the company Carelabs. This type of filing is specifically categorized as a Major Shareholding Notification.
2020-11-11 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing titled '최대주주 변경을 수반하는 주식 담보제공 계약 체결' (Execution of Stock Collateral Agreement involving Change of Largest Shareholder) and is marked as a '정정신고(보고)' (Correction Report). It details specific financial arrangements, collateral amounts, and contractual terms regarding share pledges. This type of disclosure is a standard regulatory requirement for listed companies in Korea (KRX) to report significant changes in share ownership or collateralization, which falls under the 'Regulatory Filings' category as it is a specific corporate disclosure that does not fit into the other specialized categories like M&A or Earnings.
2020-11-04 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Correction Report' (정정신고) for a 'Stock Collateral Provision Agreement' (주식담보제공계약). It details changes to collateral terms, including dates and amounts, and is a formal disclosure of a corporate financial event. Since it does not fit into specific categories like Earnings Release or M&A, and is a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2020-11-03 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and a subsequent '정정신고' (Amendment Report). It details the issuance of stock options to employees, including the number of shares, exercise price, and fair value calculations. This type of disclosure regarding capital structure changes and employee compensation via stock options falls under the category of Regulatory Filings (RNS) as it is a specific corporate announcement filed with the financial authorities.
2020-10-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.